Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain fog as a Long-term Sequela of COVID-19
Ali Nouraeinejad
SN Comprehensive Clinical Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Psychophysical assessment of olfactory and gustatory function in post‐mild COVID‐19 patients: A matched case‐control study with 2‐year follow‐up
Paolo Boscolo‐Rizzo, Thomas Hummel, Sara Invitto, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 10, pp. 1864-1875
Open Access | Times Cited: 25
The functional and structural changes in the hippocampus of COVID-19 patients
Ali Nouraeinejad
Acta Neurologica Belgica (2023) Vol. 123, Iss. 4, pp. 1247-1256
Open Access | Times Cited: 15
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 6
A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome
Adrian Vasile Bota, Iulia Bogdan, David Vladut Razvan, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 751-762
Open Access | Times Cited: 5
Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection
Jonathan A. B. Villareal, Tim Bathe, Gabriela P. Hery, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Exploring the experiences of cognitive symptoms in Long COVID: a mixed-methods study in the UK
Amy Miller, Ning Song, Manoj Sivan, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e084999-e084999
Open Access
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant)
Paul Foret-Bruno, Roz Shafran, Terence Stephenson, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 989-994
Open Access | Times Cited: 4
Depression and brain fog as long-COVID mental health consequences: Difficult, complex and partially successful treatment of a 72-year-old patient—A case report
Māris Taube
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 11
Long COVID: An approach to clinical assessment and management in primary care
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo
South African Family Practice (2023) Vol. 65, Iss. 1
Open Access | Times Cited: 10
The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
Agata Bielecka‐Dąbrowa, Agata Sakowicz, Katarzyna Gryglewska-Wawrzak, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1559-1559
Open Access | Times Cited: 3
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients
Roberta Bulla, Lucrezia Rossi, Giovanni Furlanis, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Subjective brain fog: a four-dimensional characterization in 25,796 participants
Ali Alim‐Marvasti, Matteo Ciocca, Narayan Kuleindiren, et al.
Frontiers in Human Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Long COVID management: a mini review of current recommendations and underutilized modalities
Tiffany K. Dietz, Kirsten N. Brondstater
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Cortical GABA Levels Are Reduced in Post-Acute COVID-19 Syndrome
Ksenija Marinković, D. R. White, A. Myers, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 5
Advanced magnetic resonance neuroimaging techniques: feasibility and applications in long or post-COVID-19 syndrome - a review
Sana Mohammadi, Sadegh Ghaderi
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 3, pp. 1584-1589
Open Access | Times Cited: 1
Post-COVID-19 cognitive symptoms in patients assisted by a teleassistance service: a retrospective cohort study
Lívia Paula Freire Bonfim, Thais Rotsen Correa, Bruno Cabaleiro Cortizo Freire, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Evaluating qigong as integrative support for COVID-19 and Long-COVID-19 rehabilitation: a systematic review
Michele Antonelli, Davide Donelli
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 1
Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection
Jonathan A. B. Villareal, Tim Bathe, Gabriela P. Hery, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Adaptation and Validation of the Turkish Version of the Brain Fog Scale
Murat Baş, Meryem Kahrıman, Cansu Gençalp, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 6, pp. 774-774
Open Access | Times Cited: 1
Long COVID Brain Fog Treatment: Findings from a Pilot Randomized Controlled Trial of Constraint-Induced Cognitive Therapy
Gitendra Uswatte, Edward Taub, Karlene Ball, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Identification of Natural Compounds for Long COVID Based on Hub Gene Biomarkers and Repurposed Drugs
Dinesh Davagandhi, Suresh Kumar
(2024)
Open Access | Times Cited: 1
Neurocognitive changes in a patient receiving esketamine for treatment-resistant depression
Carolyn F. Kundert, Robert Sobule, Muaid Ithman
JAAPA (2024) Vol. 37, Iss. 9, pp. 28-30
Closed Access | Times Cited: 1
Addressing Long COVID Sequelae and Neurocovid: Neuropsychological Scenarios and Neuroimaging Findings
Alessia Celeghin, Mario Stanziano, Sara Palermo
Advances in experimental medicine and biology (2024), pp. 143-164
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top